Conference Presentations (text)

Conference presentations                     

(Last updated 03 August 2020)

 

2020 conference presentations

 

Incidence and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the UK. C Van Halsema, H Okhai, T Hill, C Sabin. 

BHIVA Autumn 2020 conference.

 

Does the menopause have an impact on virological outcomes and engagement in care in UK CHIC participants? H. Okhai, S Tariq, F Burns, Y Gilleece, R Dhairyawan, C Sabin.

BHIVA Autumn 2020 conference. Oral.

 

The impact of pregnancy on engagement of care of women living with HIV in the UK CHIC Study.

H Okhai, S Tariq, F Burns, Y Gilleece, R Dhairyawan, C Sabin.

Will be presented at BHIVA Autumn 2020 conference. Oral.

 

Understanding patterns of early viral rebound in the current ART era: the UK CHIC study

H. Okhai, S Collins, A Phillips, A Rodger, T Hill, C Sabin.

BHIVA Autumn 2020 conference. Poster.

 

Antiretroviral treatment uptake and outcomes in heterosexual people living with HIV in the United Kingdom according to ethnic group. R Dhairyawan, H Okhai, T Hill, C Sabin.

BHIVA Autumn 2020 conference.Oral.

 

 

2019 conference presentations

 

Use of emtricitabine/lamivudine following detection of the M184V/I HIV-1 resistance mutation.

IWHOD 2019 O Stirrup, D Asboe, A Pozniak, C Sabin, R Gilson, N Mackie, D Dunn on behalf of the UK HIV Drug Resistance Database and the UK Collaborative HIV Cohort.

23nd International Workshop on HIV and Hepatitis Observational Databases (IWHOD). March 2019, Athens, Greece.

  

Clinical outcomes of young people with perinatal HIV following transfer from paediatric to adult care in the UK.

H Asad, I J Collins, R Goodall, C Sabin, A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee.

CHIVA Conference, London, UK, March 2019. Oral.

 

 

2018 conference presentations

 

Mortality and AIDS-defining events among young people with PHIV following transition to adult care in the UK. H Asad, IJ Collins, R Goodall, C Sabin, A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee.

10th International Workshop on HIV Pediatrics, Amsterdam, Netherlands, 2018. Poster.

 

Severe immunosuppression and viral failure in adult care among antiretroviral therapy-experienced young people with HIV in the UK. H Asad, C Sabin, IJ Collins, R Goodall, A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee.

10th International Workshop on HIV Pediatrics, Amsterdam, Netherlands, 2018. Oral.

 

Severe immunosuppression in adult care in antiretroviral therapy-experienced young people with perinatal HIV in the UK. H Asad, C Sabin, IJ Collins, R Goodall, A Judd on behalf of the CHIPS and UK CHIC Steering Committees.

22nd International Workshop on HIV and Hepatitis Observational Databases (IWHOD), Fuengirola, Spain, March 2018. Oral.

 

Linking patients with perinatal HIV across paediatric and adult care in the UK. H Asad, IJ Collins, R Goodall, C Sabin, C Chau, A Brown, V Delpech, A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee,the HIV surveillance team at Public Health England and the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted infections at UCL.

22nd International Workshop on HIV and Hepatitis Observational Databases (IWHOD), Fuengirola, Spain, March 2018. Oral.

 

Liver ultrasound to evaluate patients with HIV and hepatitis B/C co-infection: coverage and findings from the UK CHIC Study.

L Garvey, S Jose, A Thornton, A Rodger, S Baghani, R Gilson, J Main, C Taylor, D Dunn,  D Chadwick, A Scarborough, E Youssef, C Leen, M Gompels, S Kegg, A Schwenk, M Nelson and C Sabin.

4th Joint Conference of the British HIV Association (BHIVA) with the British Association for

Sexual Health and HIV (BASHH), 2018, Poster P394.

HIV Medicine 2018; 19 (Suppl. 2), s21-s152.

 

Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008-2015.

A Tostevin, D Dunn, O Stirrup, N Mackie, D Asboe, A Posniak, D Churchill, A Leigh-Brown, C Sabin, E Smit, D Pillay, S Collins and AM Geretti.

4th Joint Conference of the British HIV Association (BHIVA) with the British Association for

Sexual Health and HIV (BASHH), 2018, Poster P363.

HIV Medicine 2018; 19 (Suppl. 2), s21-s152.

 

Chronic kidney disease in HIV populations of African descent in the UK.

S Jose, L Hamzah, R Jones, D Williams, A Winston, F Burns, C Sabin, F Post.

[CROI Abstract 731]. In Special Issue: Abstracts From the 2019 Conference on Retroviruses and Opportunistic Infections. Top Antivir Med. 2018; 26 (suppl 1):319s. Poster.

 

 

2017 conference presentations

 

Factors associated with rapid eGFR decline in patients receiving TDF and/or ATV.

L Hamzah, S Jose, R Jones, D Williams, D Chadwick, A Phillips, C Sabin, F Post.

Conference on retroviruses and opportunistic infections (CROI) 2017. Poster 650.

[CROI Abstract 650]. Top Antivir Med.2017;25 (suppl 1):273s.

 

A time-updated continuum of care in a UK cohort

A Howarth, T Hill, F Burns, C Sabin, S Jose and V Delpech.

23nd Annual Conference of the British HIV Association (BHIVA), 2017, Oral O15.

HIV Medicine 2017; 18 (Suppl. S1), 3–13.

 

Integrase strand transfer inhibitors compared to other agents used in first ART regimens and the risk of virological failure in people living with HIV in the United Kingdom, 2012-2014.

K El Bouzidi, S Jose, A Phillips, A Pozniak, A Ustianowski, M Gompels, A Winston, D Dunn, C Sabin, on behalf of the UK CHIC Study.

16th European AIDS Conference 2017 Poster PE9/6.

 

 

2016 conference presentations

 

Impact of transmitted thymidine analogue mutations on responses to first-line ART.

AM Geretti, E White, A Beloukas, C Orkin, A Tostevin, P Tilston, D Chadwick, C Sabin, D Dunn; for the HIV Drug Resistance Database and CHIC Study.

Conference on retroviruses and opportunistic infections (CROI) 2016. Poster 482.

[CROI Abstract 482]. Top Antivir Med.2016;24(e-1:189).

 

No effect of HIV-1 subtype C on virological failure rate with first-line TDF regimens.

E White, E Smit, D Churchill, S Collins, C Booth, A Tostevin, C Sabin, D Pillay, D Dunn; for the HIV Drug Resistance Database and the UK Collaborative HIV Cohort.

Conference on retroviruses and opportunistic infections (CROI) 2016. Poster 484.

[CROI Abstract 484]. Top Antivir Med.2016;24(e-1):190.

 

Quality of cause-of-death reporting in an on-going UK cohort study.

S Jose, T Hill, S Pett, C Sabin, F Post, A Arenas-Pinto, V Delpech and S Croxford.

22nd Annual Conference of the British HIV Association (BHIVA), 2016, Poster P126.

HIV Med 2016; 17 (Suppl. 1), 14-71. P126

 

Patients with perinatal HIV transitioning to adulthood in the UK: clinical outcomes in adult care.

J Collins, F Parrott, C Sabin, T Hill, S Jose, A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the UK Collaborative HIV Cohort Study (CHIC).

8th International Workshop on HIV Pediatrics, 2016. Abstract P_82.

Reviews in Antiviral Therapy & Infectious Diseases 2016_7.

 

Patients with perinatal HIV transitioning to adulthood in the UK: clinical outcomes in adult care.

J Collins, F Parrott, C Sabin, T Hill, S Jose, A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the UK Collaborative HIV Cohort Study (CHIC).

20th International Workshop on HIV Observational Databases, 2016.

 

Patients with perinatal HIV transitioning to adulthood in the UK: clinical outcomes in adult care.

F Parrott, C Sabin, J Collins, T Hill, S Jose and A Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the UK Collaborative HIV Cohort Study (CHIC).

2nd Adolescent Transition Workshop, 2016. Oral.

 

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.

S Jose, M Nelson, A Phillips, D Chadwick, R Trevelion, R Jones, D Williams, L Hamzah, C Sabin, F Post.

International Congress of Drug Therapy in HIV Infection 2016.

J Int AIDS Soc 2016, 19 (Suppl 7), P218 Poster.

 

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naïve and -experienced patients in the UK.

K El Bouzidi, E White et al.,

International Congress of Drug Therapy in HIV Infection?  2016

 

 

2015 conference presentations

 

Ongoing contribution of AIDS deaths in the HAART era.

S Jose, S Pett, A Arenas-Pinto, S Croxford, V Delpech, F Post and C Sabin for the UK Collaborative HIV Cohort (CHIC) Study.

15th European AIDS Conference 2015 Poster PE12/7

 

Age, gender, risk group, cohort size and year of study effect on the performance indicator of CD4 count at HIV presentation: a UK CHIC study on late diagnosis performance.

M Gompels, S Michael, M May, S Jose, C Sabin on behalf of UK CHIC.

15th European AIDS Conference 2015 Poster BPD2/4

 

Outcomes after 2 years on antiretroviral therapy (ART): comparison of women who were ART-naïve and women who previously used short-course ART in pregnancy.

S Huntington, C Thorne, J Anderson, ML Newell, GP Taylor, D Pillay, T Hill, P Tookey, C Sabin for UK CHIC and the NSHPC.

15th European AIDS Conference 2015 Poster PS6/4

 

Using the Programmatic Compliance Score (PCS) to estimate intitial HIV care among HIV-positive individuals starting antiretroviral therapy in the United Kingdom and Canada.

M Irick, S Patterson, H Samji, S Jose, H Wong, M Fisher, A Phillips, J Zhu, V Lima, C Cooper, J Raboud, J Montaner, C Sabin and R Hogg on behalf of Canadian Observational Cohort (CANOC) and UK Collaborative HIV Cohort (CHIC) Study Collaboration.

19th International Workshop on HIV Observational Databases, 2015. Poster 129.

 

The effect of duration of previously untreated HIV infection on CD4:CD8 ratio recovery after initiation of antiretroviral therapy.

S Jose, A Winston, K Porter, C Sabin.

19th International Workshop on HIV Observational Databases, 2015. Poster 108.

 

Development of a new measure to characterise retention in outpatient HIV care.

A Howarth, F Burns, V Apea, S Jose, T Hill, C Sabin.

19th International Workshop on HIV Observational Databases, 2015. Poster 61

 

Investigating associations between a dynamic measure of retention-in-care (RIC) and clinical outcomes in the presence of time-varying confounding and reverse causality.

C Sabin, A Howarth, S Jose, T Hill, V Apea, F Burns on behalf of UK CHIC.

19th International Workshop on HIV Observational Databases, 2015. Oral 33

 

Development of a new measure to characterise engagement in outpatient HIV care.

A Howarth, F Burns, S Jose, T Hill, C Sabin, V Apea.

21st Annual Conference of the British HIV Association (BHIVA), 2015, Poster 171.

HIV Medicine 2015; 16 (Suppl. 2), 12–77.

 

Investigating associations between a new measure of engagement in-care and clinical outcomes in the UK Collaborative HIV Cohort (UK CHIC) study.

C Sabin, A Howarth, S Jose, T Hill, F Burns, V Apea.

21st Annual Conference of the British HIV Association (BHIVA), 2015, Oral 2.

 

Treatment for hepatitis C infection in the UK Collaborative HIV Cohort (UK CHIC) study.

A Rodger, A Thornton, C Sabin, S Jose, D Dunn, R Gilson, S Bhagani,

D Chadwick, M Fisher, J Main, C Taylor, M Nelson.

21st Annual Conference of the British HIV Association (BHIVA), 2015, Oral 20.

 

Initiation of anti-retrovirals in HIV/HCV-coinfected MSM: Are we too late?

T Martin, M Nelson, S Jose, A Thornton, C Sabin, N Martin, M Hickman.

21st Annual Conference of the British HIV Association (BHIVA), 2015, Oral 22.

HIV Medicine 2015; 16 (Suppl. 2), 1-11.

 

Hepatitis B treatment strategies and virological outcomes in the UK Collaborative HIV Cohort (UK CHIC) study.

A Thornton, C Sabin, S Jose, A Rodger, D Dunn, R Gilson, S Bhagani, D Chadwick, M Fisher, J Main, M Nelson, C Taylor.

21st Annual Conference of the British HIV Association (BHIVA), 2015, Poster 65.

HIV Medicine 2015; 16 (Suppl. 2), 12–77.

 

K65R detected more frequently in HIV-1 subtype C viruses at virological failure. [CROI Abstract 596].

E Smit, E White, D Clark, D Churchill, H Zhang, S Collins, D Pillay, A Tostevin, D Dunn, on behalf of UKHDRD and UKCHIC.

Conference on retroviruses and opportunistic infections (CROI) 2015. Poster 596.

[CROI Abstract 596]. Top Antivir Med. 2015;23(e-1):255.

 

K65R detected more frequently in HIV-1 subtype C viruses at virological failure.

E Smit, E White, D Clark, D Churchill, H Zhang, S Collins, D Pillay, A Tostevin, D Dunn on behalf of UKHDRD and UKCHIC.

International HIV Drug Resistance Workshop, Seattle 2015. Abstract 89.

 

Imputing viral subtype in time to virological failure analyses.

E White, D Dunn on behalf of UK HIV drug Resistance database and UK CHIC.

19th International Workshop on HIV Observational Databases, 2015. Poster 60.

 

 

2014 conference presentations

 

Detection of resistance mutations and CD4 slopes individuals experiencing sustained virological failure.

A Schultze, R Paredes, C Sabin, AN Phillips, D Pillay, O Kirk, JD Lundgren, A Pozniak, M Nelson, A Cozzi-Lepri, on behalf of Eurosida in Eurocoord.

International Congress of Drug Therapy in HIV Infection, 2014.

J Int AIDS Soc 2014, 17(Suppl 3):19737.

 

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study.

J O’Connor, C Smith, F Lampe, M Johnson, C Sabin, A Phillips.

International Congress of Drug Therapy in HIV Infection, 2014.

J Int AIDS Soc 2014, 17(Suppl 3):19527.

 

Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014-2018.

A Hill, T Hill, S Jose, A Pozniak.

International Congress of Drug Therapy in HIV Infection, 2014.

J Int AIDS Soc 2014, 17(Suppl 3):19497.

 

Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?

S Huntington, C Thorne, J Anderson, ML Newell, G Taylor, D Pillay, T Hi ll, P Tookey, C Sabin.

International Congress of Drug Therapy in HIV Infection, 2014.

J Int AIDS Soc 2014, 17(Suppl 3):19486.

 

End-stage kidney disease and kidney transplantation in HIV-positive patients in the UK Collaborative HIV Cohort (CHIC) study.

S Jose, E Gathogo, J Booth, S McAdoo, E Kumar, M Rayment, C Leen, D Williams, F Post and C Sabin.

Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014. Oral 25.

HIV Medicine 2014; 15 (Suppl. 3), 1-16.

 

Factors associated with intervals between visits to HIV outpatient clinics.

A Evans, C Sabin, V Apea, S Jose, T Hill and F Burns.

Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014. Poster P1.

HIV Medicine 2014; 15 (Suppl. 3), 17-159.

 

Treatment switches following periods of low-level viraemia.

S Jose, E Smit, F Martin, D Dunn, N Mackie, D Churchill and C Sabin.

Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014. Poster 156.

HIV Medicine 2014; 15 (Suppl. 3), 17-159.

 

Viral hepatitis testing patterns among HIV-positive individuals in the UK Collaborative HIV Cohort (UK CHIC) study.

A Thornton, S Bhagani, A Burroughs, D Chadwick, D Dunn, M Fisher, R Gilson, S Jose, J Main, M Nelson, A Rodger, C Taylor and C Sabin.

Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014. Poster 236.

HIV Medicine 2014; 15 (Suppl. 3), 17-159.

 

A comparison of virological outcomes among HIV-positive individuals receiving HAART in Canada and the UK.

S Jose, K Chan, H Samji, A Cescon, T Hill, S Shurgold, A Phillips, R Hogg and C Sabin.

Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014. Poster 325.

HIV Medicine 2014; 15 (Suppl. 3), 17-159.

 

Hepatitis B infection among individuals attending for care in the UK Collaborative HIV Cohort (CHIC) Study.

A Thornton, S Bhagani, A Burroughs, D Chadwick, D Dunn, M Fisher, R Gilson, S Jose, J Main, A Rodger, C Sabin, C Taylor and M Nelson.

Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014. Poster 375.

HIV Medicine 2014; 15 (Suppl. 3), 17-159.

 

Changes to antiretroviral therapy following periods of low-level viraemia.

S Jose, E Smit, F Martin, D Dunn, NE Mackie, DR Churchill and C Sabin on behalf of the UK CHIC Study Steering Committee.

18th International Workshop on HIV Observational Databases, 2014. Oral 19.

 

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) Study.

J O’Connor, C Smith, F Lampe, C Sabin and A Phillips on behalf of the UK Collaborative HIV Cohort (UK CHIC) Scientific Steering Committee.

18th International Workshop on HIV Observational Databases, 2014. Poster 71.

 

Mortality among ART recipients: a comparison between patients in the United Kingdom and Canada.

S Patterson, H Samji, K Chan, A Cescon, S Jose, S Shurgold, C Sabin and RS Hogg on behalf of the CANOC-UK CHIC Collaboration.

18th International Workshop on HIV Observational Databases, 2014. Poster 114.

 

Comparative analysis of late initiation of HIV treatment between Canada and the UK, 2000-2011.

G Colley, A Cescon, H Samji, K Chan, S Jose, S Shurgold, C Sabin and RS Hogg on behalf of the CANOC-UK CHIC Collaboration.

18th International Workshop on HIV Observational Databases, 2014. Poster 121.

 

Detection of NNRTI resistance mutations after interrupting NNRTI-based regimens.

V Cambiano, H Castro, D Chadwick, E Smit, AM Geretti, D Dunn, A Phillips, on behalf of UK HIV Drug Resistance Database and UK CHIC study.

Conference on retroviruses and opportunistic infections (CROI) 2014. Poster 593.

[CROI Abstract 593].Top Antivir Med.2014;22(e-1):291.

 

Spectrum of HIV-associated kidney disease in the era of combination antiretroviral therapy.

J Booth, L Hamzah, S Jose, S McAdoo, E Kumar, C Horsfield, P O’Donnell, R Jones, C Sabin, FA Post.

Conference on retroviruses and opportunistic infections (CROI) 2014. Poster 793.

[CROI Abstract 793].Top Antivir Med.2014;22(e-1):410.

 

End-stage kidney disease and kidney transplantation in HIV-positive patients.

EN Gathogo, S Jose, J Booth, SP McAdoo, EA Kumar, M Rayment, C Leen, D Williams, C Sabin and F Post.

Conference on retroviruses and opportunistic infections (CROI) 2014. Poster 800.

[CROI Abstract 800].Top Antivir Med.2014;22(e-1):414.

 

HIV-immune complex kidney disease: risk factors and progression to end-stage kidney disease.

JW Booth, Hamzah L, Jose S, SP McAdoo, T Turner-Stokes, C Horsfield, PJ O’Donnell, J Baharani, E Kingdon, BM Hendry, R Hilton, J Levy, C Sabin, FA Post, JO Connolly.

British Renal Society Conference 2014. Abstract 1908 Oral.

 

 

2013 conference presentations

 

The impact of age on associations between HIV-disease markers (immunological and virological) and systemic markers of metabolic function in therapy-naïve HIV-infected subjects in the UK Collaborative HIV Cohort (CHIC).

M Samuel, S Jose, A Winston and C Sabin.

19th Annual Conference of the British HIV Association (BHIVA), 2013. Poster 82.

HIV Medicine 2013; 14 (Suppl. 2), 12-77.

 

HLA B*5701 positivity, disease status and response to combination antiretroviral therapy (cART) in the UK Collaborative HIV Cohort (CHIC) study.

S Jose, C Sabin, C Leen and D Chadwick for the UK CHIC Study.

19th Annual Conference of the British HIV Association (BHIVA), 2013. Poster 144.

HIV Medicine 2013; 14 (Suppl. 2), 12-77.

 

Failure to achieve an adequate CD4 count response despite regular engagement in HIV care and consistent viral suppression.

J O’Connor, C Smith, F Lampe, M Johnson, C Sabin and A Phillips.

19th Annual Conference of the British HIV Association (BHIVA), 2013. Poster 46.

HIV Medicine 2013; 14 (Suppl. 2), 12-77.

 

Associations of retention-in-care (RIC) with calendar year and follow-up time may appear to be inconsistent depending on method used to to determine RIC.

CA Sabin, G Sethi and J Anderson.

17th International Workshop on HIV Observational Databases, 2013. Oral 11.

 

Prescribing decisions and virological outcomes following a wild-type resistance test result.

D Dolling, M Nelson, A Schwenk, D Churchill, A Pozniak, R Gilson, A Phillips, D Pillay and D Dunn on behalf of the UK HIV Drug Resistance Database (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study.

17th International Workshop on HIV Observational Databases, 2013. Poster 43.

 

A method for ascertaining hepatitis B virus infection status in HIV cohorts in the presence of missing and/or inconsistent data: An example from the UK CHIC study.

A Thornton, R Gilson and C Sabin.

17th International Workshop on HIV Observational Databases, 2013. Poster 89.

 

Rapid Increase in the Frequency of Wild Type HIV-1 Drug Resistance Reports among ART-experienced Patients: UK.

D Dolling, M Nelson, A Schwenk, D Churchill, D Pillay, D Dunn, and UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.

20th Conference on Retroviruses and Opportunistic Infections, 2013.

 

 

2012 conference presentations

 

The emergence of drug resistant HIV variants at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine within the UK CHIC cohort.

N Bulteel, M Nelson, D Churchill and C Sabin.

18th Annual Conference of the British HIV Association (BHIVA), 2012. Oral O30.

HIV Medicine 2012; 13 (Suppl. 1), 1-11.

 

Pregnancies among women seen for HIV-clinical care – predictors and trends over time.

S Huntington, C Thorne, J Anderson, M-L Newell, G Taylor, D Pillay, T Hill, P Tookey and C Sabin.

18th Annual Conference of the British HIV Association (BHIVA), 2012. Poster P76.

HIV Medicine 2012; 13 (Suppl. 1), 86–91.

 

Phylogenetic analysis of HIV transmission among different ethnic MSM groups: UK.

G Sethi, S Edwards, E Fearnhill, D Dunn, V Delpech, C Sabin, A Phillips, D Pillay, A Leigh-Brown, S Hué and UK HIV Drug Resistance Database and Databases for HIV: Integration, Collaboration & Engagement Project.

19th Conference on Retroviruses and Opportunistic Infections, 2012.

 

Using private record linkage to facilitate more accurate cohort analysis.

E Durham, N Lea, T Hill, A Brown, V Delpech and C Sabin.

16th International Workshop on HIV Observational Databases, 2012. Poster 98.

 

Patterns of retention and clinical care among HIV-positive men in the UK CHIC Study.

G Sethi, S Edwards, J Anderson, C Sabin, for the UK Collaborative HIV Cohort (CHIC) Study.

11th International International Congress on Drug Therapy in HIV Infection, 2012. Poster P107.

Journal of the International AIDS Society 2012, 15(Suppl 4):18395.

 

Life expectancy of HIV-1-positive individuals approaches normal conditional on repsonse to antiretroviral therapy: UK Collaborative HIV Cohort Study.

M May, M Gompels and C Sabin.

11th International International Congress on Drug Therapy in HIV Infection, 2012. Oral O133.

Journal of the International AIDS Society 2012, 15(Suppl 4):18078.

 

Recovery of dGFR in patients who develop renal complications on tenofovir.

S Jose, L Hamzah, L Campbell, C Sabin, F Post, for the UK CHIC study.

11th International International Congress on Drug Therapy in HIV Infection, 2012.

Journal of the International AIDS Society 2012, 15(Suppl 4):18137.

 

Assessment of patient complexity using routinely collected data: The UK CHIC study.

C Sabin and V Delpech, for the UK Collaborative HIV Cohort (CHIC) Study.

11th International International Congress on Drug Therapy in HIV Infection, 2012.

Journal of the International AIDS Society 2012, 15(Suppl 4):18133.

 

Has a Limit to the Decline in Transmitted Drug Resistance Been Reached? Evidence from a Large Surveillance Study of UK-acquired Infections.

D Dolling, C Sabin, V Delpech, E Smit, A Pozniak, I Williams, AM Geretti, N Mackie, D Pillay, D Dunn, and UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study.

19th Conference on Retroviruses and Opportunistic Infections, 2012. Abstract 732.

 

 

2011 conference presentations

 

Hepatitis B virus coinfection in HIV-infected patients in the UK Collaborative HIV Cohort (UK CHIC) study.

H Price, L Bansi, C Sabin and R Gilson.

17th Annual Conference of the British HIV Association (BHIVA), 2011. Oral O22.

HIV Medicine 2011; 12 (Suppl. 1), 1-13.

 

Treatment outcomes in Black and Minority Ethnic (BME) and White men who have sex with men (MSM).

G Sethi, S Edwards, R Gilson and C Sabin.

17th Annual Conference of the British HIV Association (BHIVA), 2011. Poster P5.

HIV Medicine 2011; 12 (Suppl. 1), 14–86.

 

Prevalence and predictors of protease inhibitor (PI) mutations in HIV-infected UK adults treated with ritonavir-boosted lopinavir as their first PI.

T Barber, L Harrison, D Asboe, I Williams, L Bansi, D Pillay and D Dunn.

17th Annual Conference of the British HIV Association (BHIVA), 2011. Poster P176.

HIV Medicine 2011; 12 (Suppl. 1), 14–86.

 

Baseline renal function as predictor of mortality and renal disease progression in HIV-infected patients.

F Ibrahim, L Hamzah, R Jones, D Nitsch, C Sabin, F Post, and the UK CHIC/CKD Study Group.

18th Conference on Retroviruses and Opportunistic Infections, 2011.

 

Differences in uptake of HIV care and cART between different ethnic MSM groups in the UK CHIC Study.

G Sethi, S Soni,k B Redfern, R Gilson, S Edwards, C Sabin, for UK CHIC Study.

18th Conference on Retroviruses and Opportunistic Infections, 2011.

 

 

2010 conference presentations

 

Outcomes of second-line ritonavir-boosted protease inhibitor (PI/r)-based ART after failure of a first-line nonnucleoside reverse transcriptase inhibitor (NNRTI)-based ART.

L Waters, L Bansi, D Asboe, A Pozniak, C Orkin, E Smit and A Phillips.

16th Annual Conference of the British HIV Association (BHIVA), 2010. Oral O8.

HIV Medicine 2010; 11 (Suppl. 1), 1–119.

 

Baseline renal function is an independent predictor of death and progression to severe chronic kidney disease.

F Ibrahim, L Hamzah, R Jones, L Bansi, D Nitsch, C Sabin and F Post.

16th Annual Conference of the British HIV Association (BHIVA), 2010. Oral O26.

HIV Medicine 2010; 11 (Suppl. 1), 1–119.

 

Non-uptake of HAART among HIV-positive persons with a CD4 count <350 cells/mm3.

C Kober, MA Johnson, M Fisher and C Sabin.

16th Annual Conference of the British HIV Association (BHIVA), 2010. Poster P5.

HIV Medicine 2010; 11 (Suppl. 1), 1–119.

 

Use of antiretroviral therapy during and after pregnancy among HIV-infected women already aware of their infection before conceiving.

C Sabin, S Huntington, L Bansi, C Thorne and P Tookey.

16th Annual Conference of the British HIV Association (BHIVA), 2010. Poster P154.

HIV Medicine 2010; 11 (Suppl. 1), 1–119.

 

Long-term probability of detecting HIV drug resistancein drug-naïve patients starting currently recommended first-line combination ART.

A Cozzi-Lepri, D Dunn, D Pillay, C Sabin, E Fearnhill, A Phillips, and UK HIV Drug Resistance Database and UK CHIC Study Groups.

17th Conference on Retroviruses and Opportunistic Infections, 2010.

 

The frequency and clinical implications of a discordant CD4 count and CD4 percentage.

M Gompels, C Sabin, A Phillips, D Dunn and the UK Collaborative HIV Cohort (CHIC) Study.

17th Conference on Retroviruses and Opportunistic Infections, 2010.

 

TB infections among HIV-infected Africans and Non-Africans in the UK.

A Grant, L Bansi, C Sabin, and the UK CHIC study group.

17th Conference on Retroviruses and Opportunistic Infections, 2010.

 

Does cART with greater CNS penetration prevent the development of CNS opportunistic diseases?

L Garvey, A Winston, C Sabin, and the UK CHIC Study Group.

17th Conference on Retroviruses and Opportunistic Infections, 2010.

 

Cumulative risk of extensive triple-class virologic failure in 10,603 patients followed as long as 10 years from the start of ART.

A Phillips, A Wilson, C Leen, and the UK CHIC Study Group.

17th Conference on Retroviruses and Opportunistic Infections, 2010.

 

Use of antiretroviral therapy during and after pregnancy among HIV-infected women already aware of their infection before conceiving.

S Huntington, L Bansi, C Thorne, P Tookey and C Sabin on behalf of the UK Collaborative HIV Cohort (CHIC) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC).

14th International Workshop on HIV Observational Databases, 2010. Poster 26.

 

Comparison of MDRD and CKD-EPI to estimate renal function in HIV-infected patients.

F Ibrahim, F Post, and C Sabin on behalf of the UK CHIC/CKD study group.

14th International Workshop on HIV Observational Databases, 2010. Poster 104.

 

Rate of virological failure and patterns of resistance for lamivudine/nevirapine combined with stavudine or zidovudine as first-line therapy: implications for resource-limited settings.

D Dunn, E Fearnhill, N Paton on behalf of the UK HIV Drug Resistance Database and UK CHIC.

14th International Workshop on HIV Observational Databases, 2010. Poster 123.

 

The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. 

L Harrison, H Castro (nee Green), P Cane, D Pillay, C Booth, A Phillips, AM Geretti, D Dunn, on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study (UK CHIC).

International HIV & hepatitis Virus Drug Resistance Workshop & Curative Strategies, 2010. Oral 41.

 

 

2009 conference presentations

 

Improving the quality of death data in the UK CHIC Study.

T Hill, T Hartney, T Chadborn, V Delpech and C Sabin.

15th Annual Conference of the British HIV Association, 2009, Liverpool. Poster P109.

 

Factors influencing lopinavir (LPV) and atazanavir (ATV) plasma concentration.

W Stöhr, S Khoo, D Dunn, S Gibbons, T Hill, A Winston, C Sabin and D Back.

15th Annual Conference of the British HIV Association, 2009, Liverpool. Poster P135.

 

Clinical epidemiology of end-stage renal failure in the UK.

A Hughes, L Bansi, J Connolly, S Edwards, N Mackie, M Fisher, C Sabin and F Post.

15th Annual Conference of the British HIV Association, 2009, Liverpool. Oral O5.

 

Linkage of the UK Collaborative HIV Cohort (CHIC) study and National Study of HIV in Pregnancy and Childhood (NSHPC) to assess ART patterns in pregnant women.

L Bansi, C Thorne, P Tookey and C Sabin.

15th Annual Conference of the British HIV Association, 2009, Liverpool. Poster P56.

 

Late diagnosis in the HAART era: what do we mean by a late presenter?

C Sabin on behalf of the UK CHIC Study.

13th International Workshop on HIV Observational Databases, 2009, Lisbon. Oral 1.

 

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations.

L Bansi, C Sabin, V Delpech, A Phillips on behalf of the UK CHIC Study.

13th International Workshop on HIV Observational Databases, 2009, Lisbon. Oral 26.

 

Positive and negative drug selection pressures on the N348I connection domain mutation; new insights from in vivo data.

H Price,D  Dunn, D Asboe, A Pozniak, B Gazzard, D Pillay on behalf of the UK HIV Drug Resistance Database and the UK Collaborative HIV Cohort (CHIC) Study.

The 18th International HIV Drug Resistance Workshop, 2009. Poster.

 

Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viraemia.

AM Geretti, AN Phillips, S Kaye, C Booth, NE Mackie on behalf of the UK HIV Drug Resistance Database and the UK Collaborative HIV Cohort (CHIC) Study.

The 18th International HIV Drug Resistance Workshop, 2009. Poster.

 

 

2008 conference presentations

 

Viral rebound according to specific antiretrovirals in people who attain a viral load of less than 50 copies/ml.

C Smith, A Phillips, M Fisher, and the UK Collaborative HIV Cohort (UK CHIC) study.

15th Conference on Retroviruses and Opportunistic Infections, Boston, USA. Abstract/Poster 604.

 

Do the disadvanteges of late initiation of HAART persist in patients achieving and maintaining viral load (VL) suppression for a year on HAART?

LJ Waters, M Fisher, J Anderson, C Wood and CA Sabin.

9th International Congress on Drug Therapy in HIV Infection, Glasgow, UK. Oral O422.

 

Trends in transmitted HIV drug resistance among non-B subtypes in the UK.

D Chilton, L Harrison, H Green, S Lattimore, V Delpech, D Pillay.

9th International Congress on Drug Therapy in HIV Infection, Glasgow, UK. Oral O112.

 

The frequency and clinical implications of a discordant CD4 count and CD4 percentage.

M Gompels, C Sabin, A Phillips, D Dunn and the UK Collaborative HIV Cohort (CHIC) Study.

15th Conference on Retroviruses and Opportunistic Infections, Boston, USA. Abstract 343.

 

Cumulative risk of extensive triple-class virologic failure in 10,603 patients followed as long as 10 years from the start of ART.

A Phillips, A Wilson, C Leen, and the UK CHIC Study Group.

15th Conference on Retroviruses and Opportunistic Infections, Boston, USA. Abstract 532.

 

Factors influencing efavirenz (EFV) and nevirapine (NVP) plasma concentration.

W Stöhr, S Khoo, D Dunn, S Gibbons, T Hill, A Winston, CA Sabin and D Back.

14th Annual Conference of the British HIV Association, 2008. Poster P145.

 

Association between adverse events and mortality: a validation analysis.

C Sabin, L Bansi, M Nelson, C Leen, UK CHIC Steering Committee.

14th Annual Conference of the British HIV Association, 2008. Oral O30.

 

Responses to HAART and clinical events in patients with a low CD4 count: late presenters versus late starters.

LJ Waters, MJ Fisher, J Anderson, C Wood, C Sabin for the UK CHIC Study Group.

14th Annual Conference of the British HIV Association, 2008. Oral O12.

 

Implications of post-HAART virological failure for trends in CD4 count – UK CHIC study.

R Hughes, C Sabin, JAC Sterne.

12th International Workshop on HIV Observational Databases, 2008. Poster/Abstract 58.

 

Factors influencing efavirenz and nevirapine plasma concentration.

W Stöhr, S Khoo, D Dunn, S Gibbons, T Hill, A Winston, C Sabin, D Back on behalf of the Liverpool TDM Database and the UK CHIC Study.

12th International Workshop on HIV Observational Databases, 2008. Oral/Abstract 27.

 

Does the CD4 percentage provide additional prognostic information to the absolute CD4 count in the highly active antiretroviral therapy (HAART) era?

CA Sabin, DT Dunn, AN Phillips, M Gompels. 

12th International Workshop on HIV Observational Databases, 2008. Oral/Abstract 20.

 

Is one ALT>200 enough to be defined as an ALT flare: Differentiating between ALT elevations and ALT flares.

L Bansi, J Turner, R Gilson, C Sabin.

12th International Workshop on HIV Observational Databases, 2008. Oral/Abstract 28.

 

Prevalence and patterns of antiretroviral drug resistance at low plasma HIV RNA load levels.

AM Geretti, A Phillips, S Kaye, C Booth, A Garcia, N Mackie on behalf of the UK HIV Drug Resistance Database and UK CHIC Study.

The 17th International HIV Drug Resistance Workshop, 2008.

 

Effect of HIV-1 subtype on virological and immunological responses to first-line HAART.

L Harrison, AM Geretti, H Green, D Dunn, E Fearnhill.

14th Annual Conference of the British HIV Association, 2008. Oral O10.

 

Effect of HIV-1 subtype on virological and immunological response to first-line HAART.

AM Geretti, L Harrison, H Green and D Dunn on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK CHIC Study.

6th European HIV Drug Resistance Workshop, 2008. Oral.

 

Effect of HIV-1 subtype on virological response to initial HAART regimen.

LJ Harrison, AM Geretti, HJ Green, DT Dunn.

12th International Workshop on HIV Observational Databases, 2008. Poster/Abstract 109.

 

The impact of resistance testing in ARV-naïve patients: does it guide optimal therapy selection and improve long-term outcomes?

L Bansi, AM Geretti, D Dunn, C Sabin, UK CHIC Steering Committee.

14th Annual Conference of the British HIV Association, 2008. Oral O8.

 

The impact of resistance testing in ARV naïve patients: does it guide optimal therapy selection and improve long-term outcomes?

L Bansi, AM Geretti, D Dunn, C Sabin.

12th International Workshop on HIV Observational Databases, 2008. Oral/Abstract 21.

 

Multilevel modelling to assess CD4 count response to antiretroviral therapy: Misleading inference from direct assessment of parameter estimates.

D Dunn, L Harrison, H Green, A Copas.

12th International Workshop on HIV Observational Databases, 2008. Oral/Abstract 14.

 

Long-term probability of detecting HIV drug resistance in drug-naive patients starting currently recommended first-line combination ART.

A Cozzi-Lepri, D Dunn, D Pillay, C Sabin, E Fearnhill, A Phillips and UK HIV Drug Resistance Database and UK CHIC Study Groups.

15th Conference on Retroviruses and Opportunistic Infections, Boston February 2008. Poster.

 

 

2007 conference presentations

 

Association between resistance and CD4 count change in patients on ART with ongoing viraemia.

ZV Fox, AM Gerett, B Clotet, A Cozzi-Lepri, T Hill, H Green, CA Sabin, B Ledergerber, JD Lundgren, AN Phillips for the UK Resistance Database, EuroSIDA and UK CHIC Studies.

11th International Workshop on HIV Observational databases, 2007. Poster/Abstract 95.

 

Reducing the impact of loss-to-follow-up in observational cohort studies.

L Bansi, T Hill, CA Sabin.

11th International Workshop on HIV Observational databases, 2007. Poster/Abstract 66.

 

Comparison of age/sex-specific all cause death rates in ART-naïve patients with CD4 count >350 cells/mm3 compared with the general population: proposal for a joint analysis.

R. Lodwick, AN Phillips for the UK CHIC Study.

11th International Workshop on HIV Observational databases, 2007. Oral/Abstract 20.

 

Identifying toxicity-related treatment discontinuations (TRTD) in the absence of complete data on reasons for discontinuation.

CA Sabin, C Smith, AN Phillips for the UK CHIC Study.

11th International Workshop on HIV Observational databases, 2007. Oral/Abstract 16.

 

Trends over calendar time in the prevalence of patients with extensive triple class virological failure in the UK.

A Phillips, C Leen A Wilson, C Sabin for the UK CHIC Study.

13th Annual Conference of the British HIV Association, 2007. Oral O1.

Ref. HIV Medicine, 8 (Suppl. 1), 1-8.

 

Time trends in HIV drug resistance in ART-experienced patients in the UK: impact of improved treatments and boosted protease inhibitors.

D Dunn, H Green, E Fearnhill.

13th Annual Conference of the British HIV Association, 2007. Oral O2.

Ref. HIV Medicine, 8 (Suppl. 1), 1-8.

 

Antiretroviral changes after viral load rebound in the UK Collaborative HIV Cohort (CHIC) Study.

KJ Lee, DT Dunn, CA Sabin for the UK CHIC Study Steering Committee.

11th European AIDS Conference/EACS, 2007.

 

TB incidence among HIV-infected africans in the United Kingdom.
A Grant, L Bansi, C Sabin for the UK Collaborative HIV Cohort (UK CHIC).
14th Conference on Retroviruses and Opportunistic Infections, 2007.

Long-term trends in CD4 counts in patients starting HAART: UK CHIC study.
R Hughes, C Sabin, JAC Sterne.
11th European AIDS Conference/EACS, 2007.

 

Epidemiology of non-B clade forms of HIV-1 in MSM in the UK.

J Fox, A Dudaz, H Green, D Dunn, S Kaye, M McClure and S Fidler on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK CHIC Study.

13th Annual Conference of the British HIV Association, 25-28 April 2007. Poster 117.

 

 

2006 conference presentations

 

Increased duration of viral suppression is associated with lower failure rates regardless of previous treatment failure
A.A. Benzie, L.K. Bansi, C.A. Sabin, J.C. Walsh, A.N. Phillips, on behalf of the United Kingdom Collaborative HIV Cohort (UK CHIC).

XVI International AIDS Conference, 2006. Abstract no. CDB0520 (poster)

 

Viral rebound in patients on antiretroviral therapy with viral suppression: association with extent of previous virological failure and time with viral suppression.

AA Benzie, LK Bansi, CA Sabin, J Walsh and AN Phillips on behalf of the UK CHIC Study.

12th Annual Conference of the British HIV Association, 2006. Oral O9.

Ref. HIV Medicine (2006), 7 (Suppl.1) 1-9.

 

Hepatitis C virus (HCV) co-infection in HIV-infected patients in the UK Collaborative HIV Cohort (CHIC) Study.

J Turner, L Bansi, R Gilson and C Sabin.

12th Annual Conference of the British HIV Association, 2006. Oral O14.

Ref. HIV Medicine (2006), 7 (Suppl.1) 1-9.

 

Viral rebound in people in ART with viral suppression: association with extent of previous virological failure and time with viral suppression.

AA Benzie, LK Bansi, CA Sabin, J Walsh, AN Phillips on behalf of the UK CHIC Study.

10th International Workshop on HIV Observational Databases, 2006. Poster. Abstract 73.

 

The H208Y mutation in reverse transcriptase is significantly associated with NRTI exposure, M184V and TAM mutation pathways.

AM Geretti, C Sabin, D Dunn on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort (CHIC) Study Group.

15th International HIV Drug Resistance Workshop, June 2006. Abstract 142.   

 

 

2005 conference presentations

 

Discordant CD4 and viral load responses in patients starting HAART in the UK Collaborative HIV Cohort (CHIC) Study.

A Rider, RJC Gilson, A Copas and CA Sabin, on behalf of the UK CHIC Steering Committee.

11th Annual Conference of the British HIV Association, 2005. Abstract O22. Oral/Poster.

 

CD4 counts and the risk of lymphoma in individuals with HIV in the UK.

 I Reeves, M Fisher, T Hill, C Sabin, on behalf of the UK Collaborative HIVCohort (CHIC) Steering Committee.

11th Annual Conference of the British HIV Association, 2005. Abstract O47. Oral/Poster.

 

CD4 cell count and starting ART: trends in six UK centres 1997-2002.

W Stöhr, D Dunn, K Porter, C Sabin, on behalf of UK CHIC Study.

11th Annual Conference of the British HIV Association, 2005. Abstract P23. Poster.

Virological and immunological consequences of sustained low-level viraemia (SLLV) in patients receiving HAART
T Welz, L Bansi, CA Sabin, P Easterbrook.

3rd IAS Conference on HIV Pathogenesis and Treatment, 2005. Abstract no. WePe12.9C19. (Poster)

 

What is the clinical significance of sustained low-level viraemia (SLLV) in patients on HAART?

P Easterbrook, L Bansi CA Sabin, T Welz on behalf of the UK Collaborative HIV Cohort (CHIC) Study.

11th Annual Conference of the British HIV Association, 2005. Abstract P24.Poster.

 

CD4 counts and the risk of lymphoma in individuals with HIV in the UK.

T Hill, M Fisher, C Sabin on behalf of the UK CHIC Steering Committee.

9th International Workshop on HIV Observational Databases, 2005. Abstract 36.

 

Immunological and clinical consequences of sustained low-level viraemia in patients on HAART.

P Easterbrook, L Bansi, T Welz and C Sabin.

9th International Workshop on HIV Observational Databases, 2005. Abstract 37.

 

Predictive factors and clinical outcomes in patients with multi-class drug resistant (MDR) HIV in the UK.

D Grover, L Allen, H Green, D Pillay, A Copas and S Edwards on behalf of the UK Collaborative Group on HIV Drug Resistance and UK Collaborative HIV Cohort Study (UK CHIC).

9th International Workshop on HIV Observational Databases, 2005. Abstract 57.

 

Predictors of death and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK.

D Grover, L Allen, SG Edwards, H Green, A Copas, S Forsyth and D Pillay on behalf of the UK Collaborative Group on HIV Drug Resistance and UK Collaborative HIV Cohort Study (UK CHIC).

14th International HIV Drug Resistance Workshop, 2005. Abstract 5.

 

Virological and clinical outcomes in patients with multi (three)-class drug resistance (MDR).

D Grover, L Allen, D Pillay, H Green, A Copas, S Forsyth, SG Edwards on behalf of the UK Collaborative Group on HIV Drug Resistance and UK Collaborative HIV Cohort Study (UK CHIC).

11th Annual Conference of the British HIV Association, 2005.

 

Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and I214 are associated with drug experience and specific RT mutation patterns.

AM Geretti, C Sabin, D Dunn, G Nebbia on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort (CHIC) Study Group.

14th International HIV Drug Resistance Workshop, 2005. Abstract 94.

 

 

2004 conference presentations

 

Patterns and Predictors of Antiretroviral Use at Treatment Initiation in the UK

PJ Easterbrook, AN Phillips, T Hill , C Sabin, R Matthias, M Fisher, B Gazzard, R Gilson, B Peters, G Scullard, M Johnson, D Dunn, B Evans, K Porter, A Babiker, for the UK Collaborative HIV Cohort (CHIC)

8th International Workshop on HIV Observational Databases 2004. Abstract 17.

 

Patterns and predictors of antiretroviral drug use at treatment initiation in the UK

P Easterbrook on behalf of the UK Collaborative HIV Cohort (CHIC) Study.

Ref:The XV International AIDS Conference, 2004. Abstract no. TuPeB4543
MedGenMed. 2004 Jul 11;6(3):TuPeB4543 [eJIAS. 2004 Jul 11;1(1):TuPeB4543]

 

Long term risk of development of drug resistance after starting antiretroviral therapy in routine clinical practice.

A Phillips, D Dunn, C Sabin, A Pozniak, R Matthias, A Geretti, J Clarke, D Churchill, I Williams, T Hill, H Green, K Porter, G Scullard, M Johnson, P Easterbrook, R Gilson, M Fisher, C Loveday, B Gazzard, D Pillay.

7th International Congress on Drug Therapy in HIV Infection, 2004. PL6.1.

 

Estimating resistance in drug experienced patients in the UK.

D Pillay, H Green, B Gazzard, A Pozniak, R Matthias, M Johnson, D Churchill, M Fisher, T Hill, AM Geretti, J Clarke, P Cane, C Loveday, G Scullard, P Easterbrook, K Porter, I Williams, R Gilson, C Sabin, A Phillips, and D Dunn, on behalf of the UK Collaborative Group on HIV Drug Resistance and UK Collaborative HIV Cohort Study (UK CHIC).

XIII Intl HIV Drug Resistance Workshop, 2004. Abstract 77. Poster. Oral.

Antiviral Therapy 2004; 9:S88.

 

Risk of development of drug resistance in patients starting antiretroviral therapy with three or more drugs in routine clinical practice.

AN Phillips, D Dunn, C Sabin, A Pozniak, R Matthias, AM Geretti, J Clarke,

D Churchill, I Williams, T Hill, H Green, K Porter, G Scullard, M Johnson, P Easterbrook, R Gilson, M Fisher, C Loveday, B Gazzard and D Pillay, for the UK HIV Drug Resistance Database and UK CHIC Groups

XIII Intl HIV Drug Resistance Workshop, 2004. Abstract 135. Poster.

 

 

2003 conference presentations

 

Exposure to antiretroviral therapy (ART) and its relationship to virological status: Results from the UK CHIC Study.

CA Sabin and T Hill for the UK Collaborative HIV Cohort (CHIC) Steering Committee, Royal Free and UC Medical School, London.

British HIV Association 9th Annual Conference 2003. Poster P60

 

Exposure to antiretroviral therapy in a large UK-based cohort of HIV-infected individuals: relationship to immunological and virological status.

CA Sabin on behalf of the UK Seven Centre HIV Cohort Steering Committee.

7th International Workshop on HIV Observational Databases, 2003.

 

Comparisons of efavirenz and nevirapine: have the cohorts mislead us? 

CA Sabin. 

7th International Workshop on HIV Observational Databases, 2003. Oral.

 

Are cohort studies dead?

CA Sabin. 

Ninth annual conference of the British HIV Association, 2003. Oral.

 

The UK HIV Drug Resistance Database – background and methods.

D Dunn on behalf of the UK Collaborative Group on HIV Drug Resistance.

7th International Workshop on HIV Observational Databases, 2003.

 

The UK HIV Drug Resistance Database.

D Dunn, R Matthias and T Hill on behalf of the UK Collaborative Group on HIV Drug Resistance

BHIVA 9th Annual Conference, 2003. Poster P4

HIV Medicine 2003; 4: 209 (Abstract P4).

 

Development of the UK HIV Drug Resistance Database.

DT Dunn, H Green, T Hill, D Pillay on behalf of the UK Collaborative Group on HIV Drug Resistance.

BHIVA 7th Annual Resistance Meeting, 2003. Poster.

 

The UK HIV Drug Resistance Database: development and use for national surveillance.

D Pillay1 and H Green2, on behalf of the UK Collaborative Group on HIV Drug Resistance. 1. Department of Virology, UCL  2. MRC Clinical Trials Unit, UK.

XII International HIV Drug Resistance Workshop, 2003.

 

Temporal patterns in the rate of transmitted resistance.

H.Green1, A. Pozniak2 and K. Porter1 on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK Register of HIV Seroconverters.

1MRC Clinical Trials Unit, London, UK,  2Chelsea & Westminster Hospital, London, UK  

9th European AIDS Conference, 2003. Poster. 

 

 

2002 conference presentations

 

The creation of a large UK-based cohort of HIV infected individuals: the Seven Centre HIV Database Project.

CA Sabin and T Hill on behalf of the Seven Centre HIV Database Project Steering Committee.

BHIVA 8th Annual Conference, 2002.

 

The Creation of a large UK-based cohort of HIV infected individuals: The Seven Centre HIV Database Project.

CA Sabin, K Porter, T Hill, R Matthias, R Gilson, P Easterbrook, AN Phillips, D Dunn, J Mortimer, A Babiker, M Fisher, B Gazzard, B Peters, G Scullard.

6th International Workshop on HIV Observational Databases, 2002.